We are live on ! Find out more
HSA

Hussman Strategic Advisors Portfolio holdings

AUM $463M
1-Year Est. Return 16%
This Fund
S&P 500
This Quarter Est. Return
+4.35%
1 Year Est. Return
+16%
3 Year Est. Return
+35.45%
5 Year Est. Return
+32.62%
10 Year Est. Return
+255.18%
AUM
$372M
AUM Growth
+$10.5M
Cap. Flow
+$3.66M
Cap. Flow %
0.99%
Top 10 Hldgs %
17.28%
Holding
264
New
49
Increased
26
Reduced
48
Closed
45

Top Buys

Rank Stock Value
1
FAST icon
Fastenal
FAST
+$3.95M
2
GNRC icon
Generac Holdings
GNRC
+$3.69M
3
XYL icon
Xylem
XYL
+$3.63M
4
CHRW icon
C.H. Robinson
CHRW
+$3.57M
5
AMRX icon
Amneal Pharmaceuticals
AMRX
+$3.51M

Sector Composition

Rank Sector Weight
1 Healthcare 16.62%
2 Technology 16.03%
3 Consumer Discretionary 15.97%
4 Materials 12.67%
5 Industrials 11.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GOLD
26
DELISTED
Randgold Resources Ltd
GOLD
$3.47M 0.93%
45,000
+5,000
+13% +$396K
CHRW icon
27
C.H. Robinson
CHRW
$17.3B
$3.4M 0.92%
40,700
+40,000
+5,714% +$3.57M
SIRI icon
28
SiriusXM
SIRI
$10.4B
$3.38M 0.91%
50,000
+10,000
+25% +$675K
SFM icon
29
Sprouts Farmers Market
SFM
$8.17B
$3.37M 0.91%
152,700
XYL icon
30
Xylem
XYL
$27.3B
$3.37M 0.91%
+50,000
New +$3.63M
CF icon
31
CF Industries
CF
$19.3B
$3.33M 0.9%
+75,000
New +$3.06M
GAP
32
The Gap Inc
GAP
$7.34B
$3.31M 0.89%
102,100
DAL icon
33
Delta Air Lines
DAL
$58.3B
$3.3M 0.89%
66,600
AMRX icon
34
Amneal Pharmaceuticals
AMRX
$5.91B
$3.28M 0.88%
+200,000
New +$3.51M
CVX icon
35
Chevron
CVX
$383B
$3.16M 0.85%
25,000
WOLF icon
36
Wolfspeed
WOLF
$1.24B
$3.12M 0.84%
75,000
GRMN
37
Garmin
GRMN
$57.4B
$3.11M 0.84%
51,050
SUPN icon
38
Supernus Pharmaceuticals
SUPN
$2.65B
$2.99M 0.81%
50,000
G icon
39
Genpact
G
$5.99B
$2.97M 0.8%
102,800
ETR icon
40
Entergy
ETR
$50.4B
$2.91M 0.78%
72,000
SSTK icon
41
Shutterstock
SSTK
$198M
$2.85M 0.77%
60,000
TSN icon
42
Tyson Foods
TSN
$21.4B
$2.81M 0.76%
+40,800
New +$2.84M
PSX icon
43
Phillips 66
PSX
$84.4B
$2.81M 0.76%
25,000
ESRX
44
DELISTED
Express Scripts Holding Company
ESRX
$2.76M 0.74%
+35,800
New +$2.69M
INVA icon
45
Innoviva
INVA
$1.57B
$2.76M 0.74%
200,000
LSTR icon
46
Landstar System
LSTR
$5.75B
$2.73M 0.73%
+25,000
New +$2.75M
AER icon
47
AerCap
AER
$24.1B
$2.71M 0.73%
50,000
+25,000
+100% +$1.35M
TGT icon
48
Target
TGT
$65.6B
$2.66M 0.72%
35,000
MU icon
49
Micron Technology
MU
$988B
$2.62M 0.71%
50,000
FFIV icon
50
F5
FFIV
$22.1B
$2.59M 0.7%
+15,000
New +$2.5M

Similar funds

Hussman Strategic Advisors's Q2 2018 Portfolio in Review

As of Q2 2018, Hussman Strategic Advisors held 264 positions worth $372M, up 2.9% from $361M the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Hussman Strategic Advisors's Q2 2018 filing shows 49 new, 26 increased, 48 reduced and 45 closed positions. Its largest new stake was Fastenal: 304,800 shares worth $3.67M. The largest sale was Impax Laboratories, Inc., an estimated $3.89M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 17% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Hussman Strategic Advisors's largest Q2 2018 buy was Fastenal: 304,800 shares worth $3.67M.
  • Hussman Strategic Advisors added most to C.H. Robinson in Q2 2018, an estimated $3.57M increase.
  • Hussman Strategic Advisors's biggest Q2 2018 reduction was Varian Medical Systems, Inc., cutting an estimated $2.99M.
  • Hussman Strategic Advisors fully exited Impax Laboratories, Inc. in Q2 2018, selling an estimated $3.89M.
  • Hussman Strategic Advisors's ten largest holdings make up 17% of its $372M portfolio in Q2 2018.
  • Hussman Strategic Advisors opened 49 new positions and closed 45 in Q2 2018.
  • Hussman Strategic Advisors's portfolio value rose 2.9% quarter-over-quarter to $372M.

Based on Hussman Strategic Advisors's 13F filing for Q2 2018, filed 31 Jul 2018.